PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival

PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations

(2015) Katsuhiko Nosho et al.   NEOPLASIA

Phenotype and Polyp Landscape in Serrated Polyposis Syndrome

(2012) Christophe Rosty et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population

(2012) Li-Ling Hsieh et al.   CLINICA CHIMICA ACTA

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

(2012) X. Liao et al.   CLINICAL CANCER RESEARCH

A combined oncogenic pathway signature ofBRAF,KRASandPI3KCAmutation improves colorectal cancer classification and cetuximab treatment prediction

(2012) Sun Tian et al.   GUT

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

(2012) Mai Yamauchi et al.   GUT

Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival

(2012) Xiaoyun Liao et al.   NEW ENGLAND JOURNAL OF MEDICINE

KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

(2012) Ignacio Garrido-Laguna et al.   PLoS One

PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis

(2011) C. Mao et al.   ANNALS OF ONCOLOGY

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors

(2011) Adam Naguib et al.   BMC CANCER

Oncogenic PIK3CA mutations in colorectal cancers and polyps

(2011) Vicki L.J. Whitehall et al.   INTERNATIONAL JOURNAL OF CANCER

PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors

(2011) F. Janku et al.   MOLECULAR CANCER THERAPEUTICS

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

(2011) Filip Janku et al.   PLoS One

PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis

(2011) Arantza Fariña Sarasqueta et al.   CELLULAR ONCOLOGY

Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers

(2010) Yoshifumi Baba et al.   CANCER

Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K): Differential interactions with the regulatory subunit p85 and with RAS

(2010) Li Zhao et al.   CELL CYCLE

PIK3CA mutations in KRAS and BRAF wild type colorectal cancer patients. A study of Spanish population

(2010) Marta Herreros-Villanueva et al.   MOLECULAR BIOLOGY REPORTS

PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer

(2009) H. Prenen et al.   CLINICAL CANCER RESEARCH

Biomarker Discovery: Identification of a Growth Factor Gene Signature

(2009) A Loboda et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

PIK3CAMutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer

(2009) Shuji Ogino et al.   JOURNAL OF CLINICAL ONCOLOGY

FrequentPIK3CAgene amplification and its clinical significance in colorectal cancer

(2009) Zeenath Jehan et al.   JOURNAL OF PATHOLOGY

Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype

(2008) D. R. English et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

(2008) M. Jhawer et al.   CANCER RESEARCH

Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients

(2008) M. D. Walsh et al.   CLINICAL CANCER RESEARCH

Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population

(2008) J Abubaker et al.   ONCOGENE

PIK3CAcancer mutations display gender and tissue specificity patterns

(2007) Silvia Benvenuti et al.   HUMAN MUTATION